Highlights
IIA supported (ever)1 patent
About
Transcatheter Solution for Tricuspid Regurgitation
Innoventric is a structural heart medical device company engaged primarily in the development of percutaneous solutions for tricuspid regurgitation and right heart disease. The company has developed an easily deployable percutaneous functional tricuspid valve replacement that utilizes cross-caval anchoring and an innovative multi-valve design for long-lasting blood flow regulation. Innoventric is dedicated to the development of simple yet sophisticated transcatheter solutions to significantly improve the quality of life and life span of patients with structural heart disease.
Identity
| Name | Innoventric |
|---|---|
| Slug | innoventric |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkPC_2LkKDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ city | |
| HQ address | Golda Me'ir Street 3, Ness Ziona, Israel |
Web & social
| Website | https://innoventric.com |
|---|---|
| https://www.linkedin.com/company/42845988 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business models
B2B
Tags
valveshealthcare-providersmedical-devicescardiovascular
Funding
| Total raised | $42.5M |
|---|---|
| Current stage | Series B |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}